Business – Blog Category

As India’s quick commerce and food-tech giant Zepto gears up for its highly anticipated IPO, it’s making headlines for a planned $250 million secondary share sale. This strategic move aims to increase Indian investor ownership and provide liquidity to existing shareholders. The private equity arms of Motilal Oswal Financial Services Ltd. and Edelweiss Financial Services Ltd. are in discussions to acquire shares in this secondary sale. Collaborating with these reputable financial institutions can enhance Zepto's credibility and market positioning as it approaches its IPO.

When you slip into stylish international brand footwear, you might assume they come straight from some of the world's most developed countries. But here’s a surprise—many of these brands are actually manufactured in the remote villages of Tamil Nadu. Tamil Nadu has become a global powerhouse in footwear manufacturing, producing for top brands like Nike, Puma, Crocs, and Adidas. Interestingly, non-leather footwear now makes up 86% of global footwear demand. Recognizing this shift, foreign manufacturers are pouring ₹17,550 crore into the state, a move expected to generate around 2.3 lakh jobs.

If you’ve been keeping an eye on the IT sector, you might have noticed a sudden drop in Infosys and Wipro’s stock performance on the New York Stock Exchange (NYSE). On March 20, 2025, the American Depository Receipts (ADRs) of Infosys fell by 3.6% to $17.9, while Wipro’s ADRs dropped by 3.2% to $2.97. This came right after Accenture released its second-quarter earnings and raised the lower end of its full-year revenue forecast, expecting growth between 5% and 7%, up from the earlier 4% to 7% range. Source: Economic Times

India and New Zealand have set an ambitious 60-day deadline to finalize a Free Trade Agreement (FTA), which could significantly reshape bilateral trade and investment flows between the two nations. Announced during high-level talks in early 2024, this development signals a renewed push towards economic cooperation, underpinned by India’s growing global trade ambitions and New Zealand’s strategic need to diversify its export markets. Additionally, both countries have signed a defense cooperation pact, marking a crucial step toward stronger strategic and security ties in the Indo-Pacific region.

As India’s real estate market faces a slowdown, developers are looking for ways to boost their sales. One of the key avenues they are turning to is the growing interest from Non-Resident Indians (NRIs).

Today’s market is set against a backdrop of major economic events, corporate earnings, geopolitical developments, and central bank policies that could influence market movements across Asia, the U.S., and Europe. From Wall Street’s overnight performance to crude oil fluctuations and China’s economic measures, each factor plays a role in shaping the day ahead.

In a move that marks one of the biggest private equity (PE) transactions in India’s food and snacks industry, Singapore government’s private equity arm Temasek has agreed to buy a 10% stake in Haldiram Snacks Food Pvt. Ltd. — the parent company of India's iconic snacks brand Haldiram’s. The deal, worth ₹8,500 crore, puts the total value of Haldiram’s business at a staggering ₹85,000 crore (about $10 billion), according to people familiar with the matter.

India’s digital landscape is on the verge of a major shift. Elon Musk’s Starlink, the ambitious satellite-based internet service by SpaceX, is gearing up to make its mark in the Indian market. Its arrival has set off a race among telecom giants, policymakers, and industry leaders, all eager to stake their claim in this next-gen connectivity revolution. But what does this mean for India's internet future? Let’s break it down.

Sun Pharmaceuticals, India’s largest drugmaker by market value, has announced that it will acquire Checkpoint Therapeutics, a NASDAQ-listed biotechnology company, in a deal valued at $355 million. This strategic move, announced on March 10, 2025, marks an important step for Sun Pharma as it aims to strengthen its presence in oncology and immunotherapy — two of the fastest-growing segments in the global pharmaceutical industry.

In the bustling streets of India's cities, a new kind of shopping experience has taken root: quick commerce, or Q-commerce. This model promises ultra-fast delivery of essentials, often within minutes, catering to the ever-increasing demand for speed and convenience.